MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism

Cancer Statistics, 2010

Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596 · see citing works

Trastuzumab-Induced Hepatotoxicity: A Case Report

Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,432 · see citing works

High Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer

Brocken, P., van der Heijden, E. H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus‐Oei, L. (2013) · Respiration · doi:10.1159/000347096 · Cited by 4,011 · see citing works

Comprehensive molecular characterization of clear cell renal cell carcinoma

The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485 · see citing works

Mitochondria and cancer

Wallace, D. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3365 · Cited by 2,404 · see citing works

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124 · see citing works

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001 · see citing works

Mutations of the VHL tumour suppressor gene in renal carcinoma

Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730 · see citing works

c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism

Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,707 · see citing works

Mutations in <i>SDHD</i> , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma

Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · see citing works

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635 · see citing works

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Jagt, D. L. V., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,528 · see citing works

Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells

Le, A., Lane, A. N., Hamaker, M., Bose, S., Gouw, A., Barbi, J., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Zhang, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.009 · Cited by 1,095 · see citing works

c-Myc transactivation of <i>LDH-A</i> : Implications for tumor metabolism and growth

Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092 · see citing works

MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities

Dang, C. V., Le, A., & Gao, P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0889 · Cited by 934 · see citing works

Reversible tumorigenesis by MYC in hematopoietic lineages.

Felsher, D., & Bishop, J. (1999) · Molecules and Cells · doi:10.1016/s1097-2765(00)80367-6 · Cited by 917 · see citing works

Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc

Osthus, R. C., Shim, H., Kim, S., Li, Q., Reddy, R., Mukherjee, M., Xu, Y., Wonsey, D. R., Lee, L. A., & Dang, C. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000023200 · Cited by 876 · see citing works

Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma

Seizinger, B. R., Rouleau, G. A., Ozelius, L. J., Lane, A., Farmer, G. E., Lamiell, J. M., Haines, J. L., Yuen, J., Collins, D. L., Majoor‐Krakauer, D. F., et al. (1988) · Nature · doi:10.1038/332268a0 · Cited by 662 · see citing works

Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC

Jain, M., Arvanitis, C., Chu, K., Dewey, W. C., Leonhardt, E. A., Trinh, M., Sundberg, C. D., Bishop, J. M., & Felsher, D. W. (2002) · Science · doi:10.1126/science.1071489 · Cited by 647 · see citing works

Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis

Li, F., Wang, Y., Zeller, K. I., Potter, J. J., Wonsey, D. R., O’Donnell, K. A., Kim, J., Yustein, J. T., Lee, L. A., & Dang, C. V. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.6225-6234.2005 · Cited by 615 · see citing works

MYC, Metabolism, Cell Growth, and TumorigenesisPreprint

Dang, C. V. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014217 · Cited by 600 · see citing works

Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality

Chan, D. A., Sutphin, P. D., Nguyen, P., Turcotte, S., Lai, E. W., Banh, A., Reynolds, G. E., Chi, J., Wu, J. J., Solow-Cordero, D. E., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002394 · Cited by 563 · see citing works

Fructose-1,6-bisphosphatase opposes renal carcinoma progression

Li, B., Qiu, B., Lee, D. S. M., Walton, Z. E., Ochocki, J. D., Mathew, L. K., Mancuso, A., Gade, T. P. F., Keith, B., Nissim, I., et al. (2014) · Nature · doi:10.1038/nature13557 · Cited by 535 · see citing works

HIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma

Gordan, J. D., Lal, P., Dondeti, V. R., Letrero, R., Parekh, K. N., Oquendo, C. E., Greenberg, R. A., Flaherty, K. T., Rathmell, W. K., Keith, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.016 · Cited by 493 · see citing works

Transient excess of MYC activity can elicit genomic instability and tumorigenesis

Felsher, D. W., & Bishop, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3940 · Cited by 420 · see citing works

Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney

Beroukhim, R., Brunet, J.-P., Napoli, A. D., Mertz, K. D., Seeley, A., Pires, M. M., Linhart, D., Worrell, R., Moch, H., Rubin, M. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0146 · Cited by 413 · see citing works

Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.

Vanharanta, S., Buchta, M., McWhinney, S. R., Virta, S. K., Peçzkowska, M., Morrison, C. D., Lehtonen, R., Januszewicz, A., Järvinen, H., Juhola, M., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381054 · Cited by 389 · see citing works

Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays

Kim, J.-W., Zeller, K. I., Wang, Y., Jegga, A. G., Aronow, B. J., O'Donnell, K. A., & Dang, C. V. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5923-5936.2004 · Cited by 371 · see citing works

Birt-Hogg-Dubé Syndrome, a Genodermatosis Associated with Spontaneous Pneumothorax and Kidney Neoplasia, Maps to Chromosome 17p11.2

Schmidt, L. S., Warren, M. B., Nickerson, M. L., Weirich, G., Matrosova, V. Y., Toro, J. R., Turner, M. L. C., Duray, P. H., Merino, M. J., Hewitt, S. M., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323744 · Cited by 365 · see citing works

PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study

Özcan, A., Shen, S. S., Hamilton, C., Anjana, K., Coffey, D., Krishnan, B., & Truong, L. D. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.3 · Cited by 344 · see citing works

Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES)

Robinson, M. M., McBryant, S. J., Tsukamoto, T., Rojas, C. J., Ferraris, D. V., Hamilton, S. K., Hansen, J. C., & Curthoys, N. P. (2007) · Biochemical Journal · doi:10.1042/bj20070039 · Cited by 344 · see citing works

CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation

Rakhra, K., Bachireddy, P., Zabuawala, T., Zeiser, R., Xu, L., Kopelman, A., Fan, A. C., Yang, Q., Braunstein, L., Crosby, E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.002 · Cited by 339 · see citing works

Immunohistochemical Diagnosis of Renal Neoplasms

Truong, L. D., & Shen, S. S. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0478-rar.1 · Cited by 338 · see citing works

Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer

Kiebish, M. A., Han, X., Cheng, H., Chuang, J. H., & Seyfried, T. N. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800319-jlr200 · Cited by 294 · see citing works

Desorption electrospray ionization mass spectrometry for lipid characterization and biological tissue imaging

Eberlin, L. S., Ferreira, C. R., Dill, A. L., Ifa, D. R., & Cooks, R. G. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.05.006 · Cited by 258 · see citing works

Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms

Liu, P., Cheng, H.-L. M., Santiago, S., Raeder, M. B., Zhang, F., Isabella, A. J., Yang, J., Semaan, D. J., Chen, C., Fox, E. A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2402 · Cited by 258 · see citing works

Genetic Basis of Cancer of the Kidney

Linehan, W. M., Vasselli, J. R., Srinivasan, R., Walther, M. M., Merino, M. J., Choyke, P. L., Vocke, C. D., Schmidt, L. S., Isaacs, J. S., Glenn, G. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-050013 · Cited by 248 · see citing works

Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features.

Björnsson, J., Short, M. P., Kwiatkowski, D. J., & Henske, E. P. (1996) · Europe PMC (PubMed Central) · Cited by 243 · see citing works

Molecular basis of asbestos-induced lung disease

Liu, G., Cheresh, P., & Kamp, D. W. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163942 · Cited by 213 · see citing works

Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis

Carroll, P. A., Diolaiti, D., McFerrin, L. G., Gu, H., Djukovic, D., Du, J., Cheng, P. F., Anderson, S., Ulrich, M. L., Hurley, J. B., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.024 · Cited by 202 · see citing works

Design, Synthesis, and Pharmacological Evaluation of Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide 3 (BPTES) Analogs as Glutaminase Inhibitors

Shukla, K. H., Ferraris, D. V., Thomas, A. G., Stathis, M. J., Duvall, B. R., Delahanty, G., Alt, J., Rais, R., Rojas, C. J., Gao, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301191p · Cited by 199 · see citing works

Multivariate statistical differentiation of renal cell carcinomas based on lipidomic analysis by ambient ionization imaging mass spectrometry

Dill, A. L., Eberlin, L. S., Zheng, C., Costa, A. B., Ifa, D. R., Liang Cheng, C., Masterson, T. A., Koch, M. O., Olga Vitek, A., & Cooks, R. G. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-4259-6 · Cited by 161 · see citing works

Full-Length Human Glutaminase in Complex with an Allosteric Inhibitor

DeLaBarre, B., Größ, S., Fang, C., Gao, Y., Jha, A., Jiang, F., Juanhua Song, J., Wei, W., & Hurov, J. (2011) · Biochemistry · doi:10.1021/bi201613d · Cited by 159 · see citing works

Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia

Chen, J., Futami, K., Petillo, D., Peng, J., Wang, P., Knol, J., Li, Y., Khoo, S. K., Huang, D., Qian, C.-N., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003581 · Cited by 153 · see citing works

Myc-dependent Mitochondrial Generation of Acetyl-CoA Contributes to Fatty Acid Biosynthesis and Histone Acetylation during Cell Cycle Entry

Morrish, F. M., Noonan, J., Olsen, C. P., Gafken, P. R., Fitzgibbon, M., Kelleher, J. K., VanGilst, M., & Hockenbery, D. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141606 · Cited by 152 · see citing works

Nondestructive, Histologically Compatible Tissue Imaging by Desorption Electrospray Ionization Mass Spectrometry

Eberlin, L. S., Ferreira, C. R., Dill, A. L., Ifa, D. R., Liang Cheng, C., & Cooks, R. G. (2011) · ChemBioChem · doi:10.1002/cbic.201100411 · Cited by 151 · see citing works

Detection of DNA Copy Number Changes and Oncogenic Signaling Abnormalities from Gene Expression Data Reveals MYC Activation in High-Grade Papillary Renal Cell Carcinoma

Furge, K. A., Chen, J., Koeman, J. M., Swiatek, P. J., Dykema, K. J., Lučin, K., Kahnoski, R. J., Yang, X. J., & Teh, B. T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4571 · Cited by 150 · see citing works

Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch

Giuriato, S., Ryeom, S. W., Fan, A. C., Bachireddy, P., Lynch, R. C., Rioth, M. J., van Riggelen, J., Kopelman, A. M., Passegue, E. A., Tang, F. L. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608017103 · Cited by 149 · see citing works

Alteration of the lipid profile in lymphomas induced by MYC overexpression

Eberlin, L. S., Gabay, M., Fan, A. C., Gouw, A. M., Tibshirani, R. J., Felsher, D. W., & Zare, R. N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409778111 · Cited by 143 · see citing works

Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C411Abbreviations: LDH, lactate dehydrogenase; and LDH-A4, -B4, and -C4, human lactate dehydrogenases A4, B4, and C4.

Yu, Y., Deck, J. A., Hunsaker, L. A., Deck, L. M., Royer, R. E., Goldberg, E., & Jagt, D. L. V. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00636-0 · Cited by 137 · see citing works

COLLECTING DUCT RENAL CELL CARCINOMA: CLINICAL STUDY OF A RARE TUMOR

Chao, D. H., Zisman, A., Pantuck, A. J., Gitlitz, B. J., Freedland, S. J., SAID, J. W., Figlin, R. A., & Belldegrun, A. S. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65385-2 · Cited by 136 · see citing works

MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells

Tang, S.-W., Chang, W.-H., Su, Y.-C., Chen, Y., Lai, Y.-H., Wu, P.-T., Hsu, C., Lin, W., Lai, M., & Lin, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.07.038 · Cited by 131 · see citing works

The interaction between Myc and Miz1 is required to antagonize TGFβ-dependent autocrine signaling during lymphoma formation and maintenancePreprint

van Riggelen, J., Müller, J., Otto, T., Beuger, V., Yetil, A., Choi, P. S., Kosan, C., Möröy, T., Felsher, D. W., & Eilers, M. (2010) · Genes & Development · doi:10.1101/gad.585710 · Cited by 105 · see citing works

MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma

Yamamura, S., Saini, S., Majid, S., Hirata, H., Ueno, K., Chang, I., Tanaka, Y., Gupta, A. K., & Dahiya, R. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr286 · Cited by 90 · see citing works

Population-based Assessment of Survival After Cytoreductive Nephrectomy Versus No Surgery in Patients With Metastatic Renal Cell Carcinoma

Laurent Zini, A., Umberto Capitanio, A., Perrotte, P., Claudio Jeldres, A., Shariat, S. F., Arjane, P., Widmer, H., Montorsi, F., Patard, J., & Karakiewicz, P. I. (2008) · Urology · doi:10.1016/j.urology.2008.09.022 · Cited by 72 · see citing works

Translocation of c-myc in the hereditary renal cell carcinoma associated with a t(3;8)(p14.2;q24.13) chromosomal translocation.

Drabkin, H. A., Bradley, C. M., Hart, I. M., Bleskan, J. H., Li, F. P., & Patterson, D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.6980 · Cited by 70 · see citing works

Detailed Structural Characterization of Lipid A: Electrospray Ionization Coupled with Tandem Mass-Spectrometry

Chan, S. Y., & Reinhold, V. N. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1141 · Cited by 67 · see citing works

Evaluation of LDH-A and Glutaminase Inhibition In Vivo by Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopy of Tumors

Dutta, P., Le, A., Jagt, D. L. V., Tsukamoto, T., Martinez, G. V., Dang, C. V., & Gillies, R. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0465 · Cited by 66 · see citing works

Prevention of Acute Ischemic Renal Failure by Targeted Delivery of Growth Factors to the Proximal Tubule in Transgenic Mice

Fiaschi‐Taesch, N., Santos, S., Reddy, V. T., Why, S. K. V., Philbrick, W. M., Ortega, A., Esbrit, P., Orloff, J. J., & Garcı́a-Ocaña, A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000102470.12285.c6 · Cited by 61 · see citing works

Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma

Morris, Z. S., & McClatchey, A. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902031106 · Cited by 57 · see citing works

Survival and Death Signals Can Predict Tumor Response to Therapy After Oncogene Inactivation

Tran, P. T., Bendapudi, P. K., Lin, H. J., Choi, P. S., Koh, S., Chen, J., Horng, G., Hughes, N. P., Schwartz, L. H., Miller, V. A., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002018 · Cited by 44 · see citing works

Conditionally MYC:insights from novel transgenic models

Arvanitis, C., & Felsher, D. W. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.10.043 · Cited by 42 · see citing works

Characterization of MYC-Induced Tumorigenesis by in situ Lipid Profiling

Perry, R. H., Bellovin, D., Shroff, E. H., Ismail, A. I., Zabuawala, T., Felsher, D., & Zare, R. (2013) · Analytical Chemistry · doi:10.1021/ac400479j · Cited by 38 · see citing works

Full-Length Enrich c-DNA Libraries-Clear Cell-Renal Cell Carcinoma

Tang, S.-W., & Lin, J. (2012) · Journal of Oncology · doi:10.1155/2012/680796 · Cited by 4 · see citing works

Fundamentals of Cancer Metabolism

DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · see citing works

From Krebs to clinic: glutamine metabolism to cancer therapy

Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119 · see citing works

Lipid metabolic reprogramming in cancer cells

Beloribi‐Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,392 · see citing works

Mitochondria and Cancer

Zong, W., Rabinowitz, J. D., & White, E. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.011 · Cited by 1,287 · see citing works

Glutamine reliance in cell metabolism

Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental &amp; Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021 · see citing works

The MYC oncogene — the grand orchestrator of cancer growth and immune evasion

Dhanasekaran, R., Deutzmann, A., Mahauad‐Fernandez, W. D., Hansen, A. S., Gouw, A. M., & Felsher, D. W. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00549-2 · Cited by 1,010 · see citing works

Amino acids in cancer

Lieu, E. L., Nguyen, T. A., Rhyne, S., & Kim, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0375-3 · Cited by 827 · see citing works

Glutamine Metabolism in Cancer: Understanding the Heterogeneity

Cluntun, A. A., Lukey, M. J., Cerione, R. A., & Locasale, J. W. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.01.005 · Cited by 796 · see citing works

Mitochondrial Metabolism as a Target for Cancer Therapy

Vasan, K., Werner, M., & Chandel, N. S. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.019 · Cited by 746 · see citing works

Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine

Zhang, J., Pavlova, N. N., & Thompson, C. B. (2017) · The EMBO Journal · doi:10.15252/embj.201696151 · Cited by 651 · see citing works

Metabolic reprogramming in clear cell renal cell carcinoma

Wettersten, H. I., Aboud, O. A., Lara, P. N., & Weiss, R. H. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.59 · Cited by 573 · see citing works

Glutaminolysis as a target for cancer therapy

Jin, L., Alesi, G. N., & Kang, S. (2016) · Oncogene · doi:10.1038/onc.2015.447 · Cited by 459 · see citing works

Regulation of cancer cell metabolism: Oncogenic MYC in the driver’s seat

Dong, Y., Tu, R., Liu, H., & Qing, G. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00235-2 · Cited by 405 · see citing works

The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer

Alves-Fernandes, D. K., & Jasiulionis, M. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133153 · Cited by 385 · see citing works

The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression

Tafani, M., Sansone, L., Limana, F., Arcangeli, T., Santis, E. D., Polese, M., Fini, M., & Russo, M. A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3907147 · Cited by 371 · see citing works

The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma

Miess, H., Dankworth, B., Gouw, A. M., Rosenfeldt, M., Schmitz, W., Jiang, M., Saunders, B., Howell, M., Downward, J., Felsher, D. W., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0315-z · Cited by 361 · see citing works

xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression

Ji, X., Qian, J., Rahman, S. M. J., Siska, P. J., Zou, Y., Harris, B. K., Hoeksema, M. D., Trenary, I. A., Chen, H., Eisenberg, R., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0307-z · Cited by 351 · see citing works

Targeting amino acid metabolism for cancer therapy

Lukey, M. J., Katt, W. P., & Cerione, R. A. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.12.003 · Cited by 305 · see citing works

An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer

Chen, M., Zhang, J., Sampieri, K., Clohessy, J. G., Mendez, L., González‐Billalabeitia, E., Liu, X., Lee, Y.-R., Fung, J., Katon, J. M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-017-0027-2 · Cited by 291 · see citing works

Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management

Jin, P., Jiang, J., Zhou, L., Huang, Z., Nice, E. C., Huang, C., & Fu, L. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01313-4 · Cited by 282 · see citing works

Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma

Lucarelli, G. T., Loizzo, D., Franzin, R., Battaglia, S., Ferro, M., Cantiello, F., Castellano, G., Bettocchi, C., Ditonno, P., & Battaglia, M. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1607729 · Cited by 247 · see citing works

MYC and tumor metabolism: chicken and egg

Dejure, F. R., & Eilers, M. (2017) · The EMBO Journal · doi:10.15252/embj.201796438 · Cited by 240 · see citing works

Cancer metabolism at a glance

Vazquez, A., Kamphorst, J. J., Markert, E. K., Schug, Z. T., Tardito, S., & Gottlieb, E. (2016) · Journal of Cell Science · doi:10.1242/jcs.181016 · Cited by 225 · see citing works

Oncometabolites in renal cancer

Yong, C., Stewart, G. D., & Frezza, C. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0210-z · Cited by 212 · see citing works

Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion

Fu, Q., Xu, L., Wang, Y., Jiang, Q., Liu, Z., Zhang, J., Zhou, Q., Zeng, H., Tong, S., Wang, T., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.09.030 · Cited by 211 · see citing works

Metabolic reprogramming in renal cancer: Events of a metabolic disease

Chakraborty, S., Balan, M., Sabarwal, A., Choueiri, T. K., & Pal, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188559 · Cited by 208 · see citing works

The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth

Gouw, A. M., Margulis, K., Liu, N. S., Raman, S. J., Mancuso, A., Toal, G. G., Tong, L., Mosley, A. R., Hsieh, A. L., Sullivan, D. K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.012 · Cited by 195 · see citing works

Unique Metabolic Adaptations Dictate Distal Organ-Specific Metastatic Colonization

Schild, T., Low, V., Blenis, J., & Gomes, A. P. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.001 · Cited by 185 · see citing works

Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies

Wang, Z., Liu, F., Fan, N., Zhou, C., Li, D., MacVicar, T., Dong, Q., Bruns, C. J., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.589508 · Cited by 184 · see citing works

Applications of metabolomics to study cancer metabolism

Kaushik, A. K., & DeBerardinis, R. J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.009 · Cited by 179 · see citing works

A Tale of Two Glutaminases: Homologous Enzymes with Distinct Roles in Tumorigenesis

Katt, W. P., Lukey, M. J., & Cerione, R. A. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0190 · Cited by 179 · see citing works

Ambient Mass Spectrometry Imaging Using Direct Liquid Extraction Techniques

Laskin, J., & Lanekoff, I. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04188 · Cited by 174 · see citing works

Oncogene-Directed Alterations in Cancer Cell Metabolism

Nagarajan, A., Malvi, P., & Wajapeyee, N. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.06.002 · Cited by 169 · see citing works

Genetic and metabolic hallmarks of clear cell renal cell carcinoma

Sanchez, D. J., & Simon, M. C. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.003 · Cited by 160 · see citing works

Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth

Aboud, O. A., Chen, C., Senapedis, W. T., Baloglu, E., Argueta, C. E., & Weiss, R. H. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0197 · Cited by 156 · see citing works

Global Metabolic Profiling Identifies a Pivotal Role of Proline and Hydroxyproline Metabolism in Supporting Hypoxic Response in Hepatocellular Carcinoma

Tang, L., Zeng, J., Geng, P., Fang, C., Wang, Y., Sun, M., Wang, C., Wang, J., Yin, P., Hu, C., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1707 · Cited by 151 · see citing works

Ferroptosis: mechanisms and implications for cancer development and therapy response

dos Santos, A. F., Fazeli, G., da Silva, T. N. X., & Angeli, J. P. F. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.04.005 · Cited by 151 · see citing works

Causal integration of multi‐omics data with prior knowledge to generate mechanistic hypotheses

Dugourd, A., Kuppe, C., Sciacovelli, M., Gjerga, E., Gabor, A., Emdal, K. B., Vieira, V., Bekker‐Jensen, D. B., Kranz, J., Bindels, E. M. J., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.20209730 · Cited by 149 · see citing works

Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma

Gouw, A. M., Eberlin, L. S., Margulis, K., Sullivan, D. K., Toal, G. G., Tong, L., Zare, R. N., & Felsher, D. W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617709114 · Cited by 149 · see citing works

Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy

Wolpaw, A. J., & Dang, C. V. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.006 · Cited by 147 · see citing works

A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle

Wang, B., Pei, J., Xu, S.-N., Liu, J., & Yu, J.-M. (2024) · Journal of experimental & clinical cancer research : CR · doi:10.1186/s13046-024-02994-0 · Cited by 129 · see citing works

Metabolic Symbiosis and Immunomodulation: How Tumor Cell-Derived Lactate May Disturb Innate and Adaptive Immune Responses

Morrot, A., da Fonseca, L. M., Salustiano, E. J., Gentile, L. B., Conde, L., Filardy, A. A., Franklim, T. N., da Costa, K. M., Freire-de-Lima, C. G., & Freire‐de‐Lima, L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00081 · Cited by 126 · see citing works

HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer

Lü, X., Fong, K.-W., Gritsina, G., Wang, F., Baca, S. C., Brea, L. T., Berchuck, J. E., Spisák, S., Ross, J., Morrissey, C. M., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01045-8 · Cited by 114 · see citing works

Metabolomics and Metabolic Reprogramming in Kidney Cancer

Weiss, R. H. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.01.006 · Cited by 108 · see citing works

Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging

Aboud, O. A., Habib, S. L., Trott, J. F., Stewart, B. J., Liang, S., Chaudhari, A. J., Sutcliffe-Goulden, J., & Weiss, R. H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0930 · Cited by 106 · see citing works

MYC and therapy resistance in cancer: risks and opportunities

Donati, G., & Amati, B. B. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13319 · Cited by 99 · see citing works

HIF1α Suppresses Tumor Cell Proliferation through Inhibition of Aspartate Biosynthesis

Meléndez‐Rodríguez, F., Urrutia, A. A., Lorendeau, D., Rinaldi, G., Roche, O., Böğürcü, N., Ortega‐Muelas, M., Mesa‐Ciller, C., Turiel, G., Bouthelier, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.106 · Cited by 93 · see citing works

Distinguishing malignant from benign microscopic skin lesions using desorption electrospray ionization mass spectrometry imaging

Margulis, K., Chiou, A. S., Aasi, S. Z., Tibshirani, R. J., Tang, J. Y., & Zare, R. N. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803733115 · Cited by 92 · see citing works

Metabolic reprograming of tumor-associated macrophages

Puthenveetil, A., & Dubey, S. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-2037 · Cited by 91 · see citing works

Reactive Oxygen Species, Metabolic Plasticity, and Drug Resistance in Cancer

Bhardwaj, V., & He, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103412 · Cited by 87 · see citing works

Review and perspectives on the applications of mass spectrometry imaging under ambient conditions

Perez, C. J., Bagga, A. K., Prova, S. S., Yousefi‐Taemeh, M., & Ifa, D. R. (2018) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.8145 · Cited by 86 · see citing works

Targeting GLS1 to cancer therapy through glutamine metabolism

Yu, W., Yang, X., Zhang, Q., Sun, L., Yuan, S., & Xin, Y. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02645-2 · Cited by 86 · see citing works

MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma

Bailey, S. T., Smith, A. M., Kardos, J., Wobker, S. E., Wilson, H. L., Krishnan, B., Saito, R., Lee, H. J., Zhang, J., Eaton, S. C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15770 · Cited by 83 · see citing works

Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies

Ricci, J., & Chiche, J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00556 · Cited by 82 · see citing works

MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype

Tambay, V., Raymond, V., & Bilodeau, M. (2021) · Cancers · doi:10.3390/cancers13174484 · Cited by 82 · see citing works

Novel drugs that target the metabolic reprogramming in renal cell cancer

van der Mijn, J. C., Panka, D. J., Geissler, A. K., Verheul, H. M. W., & Mier, J. W. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0154-8 · Cited by 81 · see citing works

Choosing The Right Animal Model for Renal Cancer Research

Sobczuk, P., Brodziak, A., Khan, M. I., Chhabra, S., Fiedorowicz, M., Wełniak-Kamińska, M., Synoradzki, K. J., Bartnik, E., Cudnoch‐Jędrzejewska, A., & Czarnecka, A. M. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100745 · Cited by 78 · see citing works

Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways

Kim, S. M., Roy, S. G., Chen, B., Nguyen, T. M., McMonigle, R. J., McCracken, A. N., Zhang, Y., Kofuji, S., Hou, J., Selwan, E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87148 · Cited by 77 · see citing works

Glutamic Pyruvate Transaminase GPT2 Promotes Tumorigenesis of Breast Cancer Cells by Activating Sonic Hedgehog Signaling

Cao, Y., Lin, S., Wang, Y., Chin, Y. E., Kang, L., & Mi, J. (2017) · Theranostics · doi:10.7150/thno.18992 · Cited by 76 · see citing works

Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis

Yuan, L., Zeng, G., Chen, L., Wang, G., Wang, X., Cao, X., Lü, M., Liu, X., Qian, G., Xiao, Y., et al. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.23574 · Cited by 76 · see citing works

Glutamine Synthetase: Localization Dictates Outcome

Castegna, A., & Menga, A. (2018) · Genes · doi:10.3390/genes9020108 · Cited by 73 · see citing works

Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer

Huang, F., Huffman, K. E., Wang, Z., Wang, X., Li, K., Cai, F., Yang, C., Cai, L., Shih, T. S., Zacharias, L. G., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci139929 · Cited by 72 · see citing works

Deregulated transcription factors in cancer cell metabolisms and reprogramming

Kant, R., Manne, R., Anas, M., Penugurti, V., Chen, T., Pan, B., Hsu, C.-C., & Lin, H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.001 · Cited by 74 · see citing works

Desorption electrospray ionization mass spectrometry imaging in discovery and development of novel therapies

Soudah, T., Zoabi, A., & Margulis, K. (2021) · Mass Spectrometry Reviews · doi:10.1002/mas.21736 · Cited by 71 · see citing works

Attacking the supply wagons to starve cancer cells to death

Selwan, E. M., Finicle, B. T., Kim, S. M., & Edinger, A. L. (2016) · FEBS Letters · doi:10.1002/1873-3468.12121 · Cited by 70 · see citing works

Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes

Gallo, M., Muscogiuri, G., Felicetti, F., Faggiano, A., Trimarchi, F., Arvat, E., Vigneri, R., & Colao, A. (2017) · Metabolism · doi:10.1016/j.metabol.2017.09.013 · Cited by 70 · see citing works

The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma

Zhang, Y., Zhang, S., Sun, H., & Xu, L. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02479-9 · Cited by 70 · see citing works

The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy

Hoerner, C. R., Chen, V. J., & Fan, A. C. (2019) · Kidney Cancer · doi:10.3233/kca-180043 · Cited by 68 · see citing works

Exploring the Natural Piericidins as Anti-Renal Cell Carcinoma Agents Targeting Peroxiredoxin 1

Zhou, X., Liang, Z., Li, K., Fang, W. H., Tian, Y., Luo, X., Chen, Y., Zhan, Z., Zhang, T., Liao, S., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00598 · Cited by 67 · see citing works

Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes

Tran, T. Q., Gabra, M. B. I., Lowman, X. H., Yang, Y., Reid, M. A., Pan, M., O'Connor, T. R., & Kong, M. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2002810 · Cited by 65 · see citing works

Metabolic Pathways in Kidney Cancer: Current Therapies and Future Directions

Rathmell, W. K., Rathmell, J. C., & Linehan, W. M. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.2309 · Cited by 64 · see citing works

Deciphering metabolic rewiring in breast cancer subtypes

Ogrodzinski, M. P., Bernard, J. J., & Lunt, S. Y. (2017) · Translational research · doi:10.1016/j.trsl.2017.07.004 · Cited by 64 · see citing works

PDHA1 Gene Knockout In Human Esophageal Squamous Cancer Cells Resulted In Greater Warburg Effect And Aggressive Features In Vitro And In Vivo

Liu, L., Cao, J., Zhao, J., Li, X., Suo, Z., & Li, H. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s226851 · Cited by 61 · see citing works

NRF2 in human neoplasm: Cancer biology and potential therapeutic target

Liu, Y., Lang, F., & Yang, C. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107664 · Cited by 59 · see citing works

Metabolism and immunity in breast cancer

Zhang, D., Xu, X., & Ye, Q. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0793-6 · Cited by 58 · see citing works

Metabolic changes during prostate cancer development and progression

Beier, A.-M. K., Puhr, M., Stope, M. B., Thomas, C., & Erb, H. H. H. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04371-w · Cited by 58 · see citing works

In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma

Kaushik, A., Tarangelo, A., Boroughs, L. K., Ragavan, M., Zhang, Y., Wu, C., Li, X., Ahumada, K., Chiang, J., Tcheuyap, V. T., et al. (2022) · Science Advances · doi:10.1126/sciadv.abp8293 · Cited by 55 · see citing works

In vivo Reprogramming of Cancer Metabolism by MYC

Camarda, R., Williams, J. R., & Goga, A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00035 · Cited by 56 · see citing works

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer

Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143798 · Cited by 55 · see citing works

Intestinal MYC modulates obesity-related metabolic dysfunction

Luo, Y., Yang, S., Wu, X., Takahashi, S., Sun, L., Cai, J., Krausz, K. W., Guo, X., Dias, H. B., Gavrilova, O., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00421-8 · Cited by 56 · see citing works

Involvement of Tricarboxylic Acid Cycle Metabolites in Kidney Diseases

Jiménez‐Uribe, A. P., Cruz, E. Y. H., Ramírez-Magaña, K. J., & Pedraza‐Chaverrí, J. (2021) · Biomolecules · doi:10.3390/biom11091259 · Cited by 54 · see citing works

The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma

Emberley, E. D., Pan, A., Chen, J., Dang, R., Gross, M. I., Huang, T. C., Li, W., MacKinnon, A. L., Singh, D., Sotirovska, N., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259241 · Cited by 53 · see citing works

Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital Age

Thng, D. K. H., Toh, T. B., & Chow, E. K. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.11.014 · Cited by 52 · see citing works

The HOTAIR lncRNA: A remarkable oncogenic promoter in human cancer metastasis (Review)

Chen, L., Qian, X., Wang, Z., & Zhou, X. (2021) · Oncology Letters · doi:10.3892/ol.2021.12563 · Cited by 48 · see citing works

Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy

Kumar, R., Mishra, A., Gautam, P., Feroz, Z., Vijayaraghavalu, S., Likos, E., Shukla, G. C., & Kumar, M. (2022) · Cancers · doi:10.3390/cancers14215268 · Cited by 48 · see citing works

MYC in Germinal Center‐derived lymphomas: Mechanisms and therapeutic opportunities

Bisso, A., Sabò, A., & Amati, B. B. (2019) · Immunological Reviews · doi:10.1111/imr.12734 · Cited by 48 · see citing works

Ambient ionization mass spectrometric analysis of human surgical specimens to distinguish renal cell carcinoma from healthy renal tissue

Alfaro, C. M., Jarmusch, A. K., Pirro, V., Kerian, K. S., Masterson, T. A., Liang Cheng, C., & Cooks, R. G. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9627-4 · Cited by 47 · see citing works

MALDI Orbitrap Mass Spectrometry Profiling of Dysregulated Sulfoglycosphingolipids in Renal Cell Carcinoma Tissues

Jirásko, R., Holčapek, M., Khalikova, M. A., Vrána, D., Študent, V., Prouzová, Z., & Melichar, B. (2017) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-017-1644-9 · Cited by 44 · see citing works

Glutamine metabolism in cancers: Targeting the oxidative homeostasis

Gong, T., Zheng, C., Ou, X., Zheng, J., Yu, J., Chen, S., Duan, Y., & Liu, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.994672 · Cited by 43 · see citing works

Deregulated transcription factors in the emerging cancer hallmarks

Hasan, A., Khan, N. A., Shahab Uddin, M. S., Khan, A. Q., & Steinhoff, M. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.001 · Cited by 43 · see citing works

Analyzing Tumor Metabolism In Vivo

Faubert, B., & DeBerardinis, R. J. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-121954 · Cited by 43 · see citing works

WNK1 promotes renal tumor progression by activating TRPC6‐NFAT pathway

Kim, J., Hwang, K., Eom, M., Kim, M., Park, E. Y., Jeong, Y., Park, K., & Cha, S. (2019) · The FASEB Journal · doi:10.1096/fj.201802019rr · Cited by 43 · see citing works

The delta subunit of the GABA A receptor is necessary for the GPT2-promoted breast cancer metastasis

Li, N., Xu, X. M., Liu, D., Gao, J., Gao, Y., Wu, X., Sheng, H., Li, Q., & Mi, J. (2023) · Theranostics · doi:10.7150/thno.80544 · Cited by 42 · see citing works

Metabolomic profiling of prostate cancer by matrix assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry imaging using Matrix Coating Assisted by an Electric Field (MCAEF)

Wang, X., Han, J., Hardie, D. B., Yang, J., Pan, J., & Borchers, C. H. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.12.012 · Cited by 42 · see citing works

The amino acid transporter SLC7A11 expression in breast cancer

Nath, P., Alfarsi, L. H., Ansari, R. E., Masisi, B. K., Erkan, B., Fakroun, A., Ellis, I. O., Rakha, E. A., & Green, A. R. (2023) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2291855 · Cited by 41 · see citing works

MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer

Stefan, E., & Bister, K. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_4 · Cited by 40 · see citing works

The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review

Haque, I., Subramanian, A., Huang, C. H., Godwin, A. K., Veldhuizen, P. J. V., Banerjee, S., & Banerjee, S. K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010107 · Cited by 40 · see citing works

Comparative STAT3-Regulated Gene Expression Profile in Renal Cell Carcinoma Subtypes

Robinson, R. L., Sharma, A. K., Bai, S., Heneidi, S. G., Lee, T. J., Kodeboyina, S. K., Patel, N., & Sharma, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00072 · Cited by 39 · see citing works

The blood metabolome of incident kidney cancer: A case–control study nested within the MetKid consortium

Guida, F., Tan, V. Y., Corbin, L. J., Smith-Byrne, K., Alcala, K., Langenberg, C., Stewart, I. D., Butterworth, A. S., Surendran, P., Achaintre, D., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003786 · Cited by 39 · see citing works

Upregulation of Far Upstream Element-Binding Protein 1 (FUBP1) Promotes Tumor Proliferation and Tumorigenesis of Clear Cell Renal Cell Carcinoma

Duan, J., Bao, X., Ma, X., Zhang, Y., Ni, D., Wang, H., Zhang, F., Du, Q., Fan, Y., Chen, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169852 · Cited by 37 · see citing works

The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy

Hoerner, C. R., Chen, V. J., & Fan, A. C. (2019) · Kidney Cancer · doi:10.3233/kca-180043 · Cited by 68 · see citing works

c-Myc modulates glucose metabolism via regulation of miR-184/PKM2 pathway in clear-cell renal cell carcinoma

Huang, J., Kong, W., Zhang, J., Chen, Y., Xue, W., Liu, D., & Huang, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3622 · Cited by 21 · see citing works

N‑Myc downstream‑regulated gene 2 restrains glycolysis and glutaminolysis in clear cell renal cell carcinoma

Shi, W., Xu, X., Yan, F., Wang, B., Zhao, H., Chan, A., Ren, Z., Ma, Y., Wang, F., & Yuan, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.7024 · Cited by 15 · see citing works

Abstract 3972: Novel renal cell carcinoma therapy targeting glutaminolysis

Muto, Y., Takeuchi, A., Zennami, K., Sugihara, E., Shiroki, R., Saya, H., & Sumitomo, M. (2023) · Cancer Research · doi:10.1158/1538-7445.am2023-3972

In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma

Kaushik, A., Tarangelo, A., Boroughs, L. K., Ragavan, M., Zhang, Y., Wu, C., Li, X., Ahumada, K., Chiang, J., Tcheuyap, V. T., et al. (2022) · Science Advances · doi:10.1126/sciadv.abp8293 · Cited by 55 · see citing works